New Delhi : Ministry of corporate affairs is exploring possibilities of amending the Competition Act to exempt deals in the sector from the current turnover and deal size thresholds
![]()
The government’s attempt to strike a balance between public health concerns and need for foreign direct investments (FDI) by empowering the Competition Commission of India (CCI) to monitor all foreign takeovers of Indian drug firms may have no impact. Experts feel all domestic takeovers, irrespective of the turnover, deal size or the status of the acquirer, need to be brought under strict scrutiny. Read more
Source : business-standard.com











Recent Comments